Find information on thousands of medical conditions and prescription drugs.

Osteoarthritis

Osteoarthritis (OA, also known as degenerative arthritis or degenerative joint disease, and sometimes referred to as "arthrosis" or "osteoarthrosis"), is a condition in which low-grade inflammation results in pain in the joints, caused by wearing of the cartilage that covers and acts as a cushion inside joints. As the bone surfaces become less well protected by cartilage, the patient experiences pain upon weight bearing, including walking and standing. Due to decreased movement because of the pain, regional muscles may atrophy, and ligaments may become more lax. OA is the most common form of arthritis. more...

Home
Diseases
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
Obesity
Obsessive-compulsive...
Occipital horn syndrome
OCD
Ochronosis
Oculocutaneous albinism,...
Oculopharyngeal muscular...
Odontophobia
Odynophobia
Oikophobia
Olfactophobia
Olivopontocerebellar atrophy
Omenn syndrome
Onchocerciasis
Oncocytoma
Ondine's curse
Opportunistic infections
Oppositional defiant...
Optic atrophy
Optic neuritis
Oral leukoplakia
Ornithosis
Orthostatic intolerance
Osgood-Schlatter disease
Osteitis deformans
Osteoarthritis
Osteochondritis
Osteochondritis dissecans
Osteochondroma
Osteogenesis Imperfecta
Osteomalacia
Osteomyelitis
Osteopetrosis, (generic...
Osteoporosis
Osteosclerosis
Otosclerosis
Otospondylomegaepiphyseal...
Ovarian cancer
P
Q
R
S
T
U
V
W
X
Y
Z
Medicines

The word is derived from the Greek word "osteo", meaning "of the bone", "arthro", meaning "joint", and "itis", meaning inflammation, although many sufferers have little or no inflammation.

OA affects nearly 21 million people in the United States, accounting for 25% of visits to primary care physicians, and half of all NSAID (Non-Steroidal Anti-Inflammatory Drugs) prescriptions. It is estimated that 80% of the population will have radiographic evidence of OA by age 65, although only 60% of those will be symptomatic (Green 2001). Treatment is with NSAIDs, local glucocorticoid injections, and in severe cases, with joint replacement surgery. There is no cure for OA, as it is impossible for the cartilage to grow back.

Signs and symptoms

The main symptom is chronic pain, causing loss of mobility and often stiffness. "Pain" is generally described as a sharp ache, or a burning sensation in the associated muscles and tendons. OA can cause a crackling noise (called "crepitus") when the affected joint is moved or touched, and patients may experience muscle spasm and contractions in the tendons. Occasionally, the joints may also be filled with fluid. Humid weather increases the pain in many patients.

OA commonly affects the hand, feet, spine, and the large weight-bearing joints, such as the hips and knees, although in theory, any joint in the body can be affected. Progressive degeneration of cartilage, technically known as synovium (joint lining), in the knees can lead to them curving outwards in a condition known as "bow legged". As OA progresses, the affected joints appear larger, are stiff and painful, and usually feel worse, the more they are used throughout the day, thus distinguishing it from rheumatoid arthritis.

In smaller joints, such as at the fingers, hard bony enlargements, called Heberden's nodes and/or Bouchard's nodes, may form, and though they are not necessarily painful, they do limit the movement of the fingers significantly. OA at the toes leads to the formation of bunions, rendering them red or swollen.

Causes of disease

The crucial factor in the development of OA is the wearing out and eventual disappearance of synovium, and later, all cartilage of the affected joints. OA may be divided into two types:

  • Primary OA: This type is caused by ageing. As a person ages, the water content of the cartilage increases, and the protein composition in it degenerates, thus degenerating the cartilage through repetitive use or misuse. Inflammation can also occur, and stimulate new bone outgrowths, called "spurs" (osteophyte), to form around the joints. Sufferers find their every movement so painful and debilitating that it can also affect them emotionally and psychologically.
  • Secondary OA: This type is caused by other diseases or conditions such as:
    • obesity. Obesity puts added weight on the joints, especially the knees.
    • diabetes
    • repeated trauma. Certain sports, such as weightlifting, or even football, put undue pressure on the knee joints.
    • hormonal disorders
    • osteoporosis
    • surgery to the joint structures
    • congenital hip luxation (which is genetically determined)
    • inflammatory diseases (such as Perthes' disease), and all chronic forms of arthritis (e.g. rheumatoid arthritis and gout). In gout, uric acid crystals cause the cartilage to degenerate at a faster pace.
    • People with abnormally-formed joints are more vulnerable to OA, as added stress is specifically placed on the joints whenever they move.
    • Ligamentous deterioration or instability may be a factor.

OA often affects multiple members of the same family, suggesting that there is a hereditary basis for this condition. A number of studies have shown that the there is a greater prevalence of the disease between siblings, and especially twins, indicating a hereditary basis. In the population as a whole up to 60% of OA is thought to be as a result of genetic factors.

Read more at Wikipedia.org


[List your site here Free!]


Is glucosamine effective for osteoarthritis of the knee?
From American Family Physician, 10/1/05 by Karl E. Miller

Because of the publicity it has received in the media, glucosamine has become one of the most commonly used dietary supplements in the United States. Several studies sponsored by the supplement industry have suggested that glucosamine is effective in the management of osteoarthritis. A meta-analysis of early trials of this supplement discovered methodologic problems and possible publication bias, and in two recent independent trials, glucosamine therapy was found to be ineffective for osteoarthritis. Because trials of osteoarthritis treatment are burdensome and costly, McAlindon and associates developed a method for performing clinical trials using the Internet, and used this technique to evaluate the safety and effectiveness of glucosamine in the management of knee osteoarthritis.

The authors conducted a double-blind, placebo-controlled study of glucosamine in patients with osteoarthritis. The patients were recruited and followed using the Internet. Inclusion criteria were: 45 years or older; osteoarthritis of at least one knee, as established by radiography or magnetic resonance imaging; and pain, aching, or stiffness in either knee on most days. Exclusion criteria were: a knee injection within 60 days of the study; arthroplasty of the knee; and current use of glucosamine, chondroitin, or other agents that claim to have osteoarthritis structure-modifying properties. The patients were randomized to receive 1.5 g of glucosamine or placebo daily for 12 weeks. The main outcome measure was the pain subscale on the Western Ontario and McMaster Universities Osteoarthritis Index, which includes three subscales (pain, stiffness, and function) and generates scores for each subscale as well as an overall score. Analgesia use and adverse events also were recorded.

There were 205 patients enrolled in the study. The groups receiving glucosamine and placebo did not differ with regard to pain scores, stiffness, physical function, overall scores on the Index, and analgesic use. No significant differences were noted between the patients who received glucosamine and those who received placebo when the groups were stratified for severity of osteoarthritis, glucosamine product, use of a nonsteroidal anti-inflammatory drug, and the exclusion of opiate use. The groups had similar numbers and types of adverse events recorded during the study.

The authors conclude that glucosamine, while appearing to be safe, is no more effective than placebo in treating the symptoms of knee osteoarthritis. They add that Internet-based clinical trials may provide a quick and efficient method for further studies on the effectiveness of glucosamine products.

KARL E. MILLER, M.D.

McAlindon T, et al. Effectiveness of glucosamine for symptoms of knee osteoarthritis: results from an Internetbased randomized double-blind controlled trial. Am J Med November 1, 2004;117:643-9.

COPYRIGHT 2005 American Academy of Family Physicians
COPYRIGHT 2005 Gale Group

Return to Osteoarthritis
Home Contact Resources Exchange Links ebay